208 related articles for article (PubMed ID: 25542409)
21. Nephrogenic syndrome of inappropriate antidiuresis.
Feldman BJ; Rosenthal SM; Vargas GA; Fenwick RG; Huang EA; Matsuda-Abedini M; Lustig RH; Mathias RS; Portale AA; Miller WL; Gitelman SE
N Engl J Med; 2005 May; 352(18):1884-90. PubMed ID: 15872203
[TBL] [Abstract][Full Text] [Related]
22. Chronic hyponatremia in a 19-month-old child with gross developmental delay: Answers.
Gavryutina I; Bargman R; Shaoba A; Alharash H; Mongia A
Pediatr Nephrol; 2023 Apr; 38(4):1035-1038. PubMed ID: 35748946
[No Abstract] [Full Text] [Related]
23. Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis.
Erdélyi LS; Mann WA; Morris-Rosendahl DJ; Groß U; Nagel M; Várnai P; Balla A; Hunyady L
Kidney Int; 2015 Nov; 88(5):1070-8. PubMed ID: 26131744
[TBL] [Abstract][Full Text] [Related]
24. Nephrogenic syndrome of inappropriate antidiuresis.
Levtchenko EN; Monnens LA
Nephrol Dial Transplant; 2010 Sep; 25(9):2839-43. PubMed ID: 20543212
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcomes in a family with nephrogenic syndrome of inappropriate antidiuresis.
Cho YH; Gitelman S; Rosenthal S; Ambler G
Int J Pediatr Endocrinol; 2009; 2009():431527. PubMed ID: 20148077
[TBL] [Abstract][Full Text] [Related]
26. Lack of responsiveness to 1-desamino-D arginin vasopressin (desmopressin) in male patients with nephrogenic syndrome of inappropriate antidiuresis: from bench to bedside.
Vandergheynst F; Pradier O; Beukinga I; Kornreich A; Vassart G; Decaux G
Eur J Clin Invest; 2012 Mar; 42(3):254-9. PubMed ID: 21834801
[TBL] [Abstract][Full Text] [Related]
27. [Syndrome of inappropriate antidiuresis and the current management of hyponatremia].
Lazúrová I
Vnitr Lek; 2017; 63(9):593-597. PubMed ID: 29120656
[TBL] [Abstract][Full Text] [Related]
28. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Decaux G
Semin Nephrol; 2009 May; 29(3):239-56. PubMed ID: 19523572
[TBL] [Abstract][Full Text] [Related]
29. An elderly patient with chronic hyponatremia.
Berl T
Clin J Am Soc Nephrol; 2013 Mar; 8(3):469-75. PubMed ID: 23037983
[TBL] [Abstract][Full Text] [Related]
30. Hyponatremia in neurologic patients: consequences and approaches to treatment.
Diringer MN; Zazulia AR
Neurologist; 2006 May; 12(3):117-26. PubMed ID: 16688013
[TBL] [Abstract][Full Text] [Related]
31. [Differential diagnosis and treatment of hyponatremia].
Mydlík M; Derzsiová K; Frank K
Vnitr Lek; 2013 Jun; 59(6):478-81. PubMed ID: 23808743
[TBL] [Abstract][Full Text] [Related]
32. Hyponatremia: pathophysiology, differential diagnosis and new aspects of treatment.
Gross P; Wehrle R; Büssemaker E
Clin Nephrol; 1996 Oct; 46(4):273-6. PubMed ID: 8905218
[TBL] [Abstract][Full Text] [Related]
33. Nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a paradigm for activating mutations causing endocrine dysfunction.
Rosenthal SM; Feldman BJ; Vargas GA; Gitelman SE
Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():66-70. PubMed ID: 17261972
[TBL] [Abstract][Full Text] [Related]
34. Normal acid-base equilibrium in acute hyponatremia and mixed alkalosis in chronic hyponatremia induced by arginine vasopressin or 1-deamino-8-D-arginine vasopressin in rats.
Decaux G; Crenier L; Namias B; Gervy C; Soupart A
J Lab Clin Med; 1994 Jun; 123(6):892-8. PubMed ID: 8201268
[TBL] [Abstract][Full Text] [Related]
35. Vasopressin dysregulation and hyponatremia in hospitalized patients.
Multz AS
J Intensive Care Med; 2007; 22(4):216-23. PubMed ID: 17712057
[TBL] [Abstract][Full Text] [Related]
36. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
Wong F; Blei AT; Blendis LM; Thuluvath PJ
Hepatology; 2003 Jan; 37(1):182-91. PubMed ID: 12500203
[TBL] [Abstract][Full Text] [Related]
37. Consequences of inadequate management of hyponatremia.
Adrogué HJ
Am J Nephrol; 2005; 25(3):240-9. PubMed ID: 15914973
[TBL] [Abstract][Full Text] [Related]
38. Persistent elevation of urine aquaporin-2 during water loading in a child with nephrogenic syndrome of inappropriate antidiuresis (NSIAD) caused by a R137L mutation in the V2 vasopressin receptor.
Cheung CC; Cadnapaphornchai MA; Ranadive SA; Gitelman SE; Rosenthal SM
Int J Pediatr Endocrinol; 2012 Feb; 2012(1):3. PubMed ID: 22325688
[TBL] [Abstract][Full Text] [Related]
39. Mutations of Vasopressin Receptor 2 Including Novel L312S Have Differential Effects on Trafficking.
Tiulpakov A; White CW; Abhayawardana RS; See HB; Chan AS; Seeber RM; Heng JI; Dedov I; Pavlos NJ; Pfleger KD
Mol Endocrinol; 2016 Aug; 30(8):889-904. PubMed ID: 27355191
[TBL] [Abstract][Full Text] [Related]
40. Hyponatremia during arginine vasopressin therapy in children following cardiac surgery.
Davalos MC; Barrett R; Seshadri S; Walters HL; Delius RE; Zidan M; Mastropietro CW
Pediatr Crit Care Med; 2013 Mar; 14(3):290-7. PubMed ID: 23392370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
